Therapeutic Potential and Utility of Elacridar with Respect to P-glycoprotein Inhibition: An Insight from the Published In Vitro, Preclinical and Clinical Studies

Authors: A Sandler
A Sparreboom
A Stewart
A Traxl
AA Lumen
AB Shapiro
AJ O’Neill
AS Planting
B Stordal
C Cordon-Cardo
C Kuntner
CQ Xia
DW Miller
E Fox
E Fox
E Gozalpour
ED Adane
EF Choo
EM Kemper
EM Kemper
F Imbert
F Lin
F Liu
FE O’Brien
FR Luo
G An
H Sato
H Shen
H Thomas
HA Bardelmeijer
HL Wong
HM Yao
IA Nekhayeva
IE Kuppens
J König
J Savolainen
J Schrickx
J Shi
J Souza de
J Tallkvist
J Wijnholds
JA Schrickx
JE Edwards
JJ Hendrikx
JS Lagas
JS Lagas
JW Jonker
JW Polli
K Kawamura
K Mandery
K Westphal
KE Parrish
KN Chi
KR Robillard
KW Ward
L Zuylen van
LD Cripe
LH Lê
M Bauer
M Bauer
M Ceckova
M Demeule
M Falasca
M Minocha
M Minocha
MF Fromm
MJ Zamek-Gliszczynski
MM Malingré
MR Jablonski
MT Huisman
MV Varma
NA Colabufo
NA Vries de
NR Srinivas
P Breedveld
P Zhang
R Fredriksson
R Kallem
R O’Connor
R Sane
R Sane
RK Mittapalli
RK Oberoi
RL Oostendorp
RN Montesinos
S Agarwal
S Agarwal
S Agarwal
S Barraud Lagerie de
S Bihorel
S Bihorel
S Drori
S Durmus
S Marchetti
S Patil
S Vaidhyanathan
S Warmann
SC Tang
SC Tang
SC Tang
SC Tang
SP Letrent
T Mukhopadhyay
T Sugano
T Takahata
T Yamasaki
TT Mariappan
X Declèves
Y Chen
Y Lu
YJ Lee
Z Neumanova
Publication date
Publisher: 'Springer Science and Business Media LLC'
Doi

Abstract

Abstract is not available.

Similar works

Full text

thumbnail-image

Available Versions

Crossref

redirect

info:doi/10.1007%2Fs13318-017-...

Last time updated on 06/11/2020